156 related articles for article (PubMed ID: 28663115)
1. Cigarette smoking and schizophrenia: a specific clinical and therapeutic profile? Results from the FACE-Schizophrenia cohort.
Mallet J; Le Strat Y; Schürhoff F; Mazer N; Portalier C; Andrianarisoa M; Aouizerate B; Berna F; Brunel L; Capdevielle D; Chereau I; D'Amato T; Denizot H; Dubreucq J; Faget C; Gabayet F; Lançon C; Llorca PM; Misdrahi D; Rey R; Roux P; Schandrin A; Urbach M; Vidailhet P; Fond G; Dubertret C;
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Oct; 79(Pt B):332-339. PubMed ID: 28663115
[TBL] [Abstract][Full Text] [Related]
2. Tobacco smoking is associated with antipsychotic medication, physical aggressiveness, and alcohol use disorder in schizophrenia: results from the FACE-SZ national cohort.
Mallet J; Le Strat Y; Schürhoff F; Mazer N; Portalier C; Andrianarisoa M; Aouizerate B; Berna F; Brunel L; Capdevielle D; Chereau I; D'Amato T; Dubreucq J; Faget C; Gabayet F; Honciuc RM; Lançon C; Llorca PM; Misdrahi D; Rey R; Roux P; Schandrin A; Urbach M; Vidailhet P; Fond G; Dubertret C;
Eur Arch Psychiatry Clin Neurosci; 2019 Jun; 269(4):449-457. PubMed ID: 29396753
[TBL] [Abstract][Full Text] [Related]
3. Confirmations, advances and recommendations for the daily care of schizophrenia based on the French national FACE-SZ cohort.
Fond G; Godin O; Schürhoff F; Berna F; André M; Aouizerate B; Capdevielle D; Chereau I; D' Amato T; Dubertret C; Dubreucq J; Faget C; Lançon C; Leignier S; Mallet J; Misdrahi D; Passerieux C; Pignon B; Rey R; Szoke A; Urbach M; Vidailhet P; Leboyer M; Boyer L; Llorca PM;
Prog Neuropsychopharmacol Biol Psychiatry; 2020 Jul; 101():109927. PubMed ID: 32173456
[TBL] [Abstract][Full Text] [Related]
4. Chronic low-grade peripheral inflammation is associated with severe nicotine dependence in schizophrenia: results from the national multicentric FACE-SZ cohort.
Fond G; Berna F; Andrianarisoa M; Godin O; Leboyer M; Brunel L; Aouizerate B; Capdevielle D; Chereau I; D'Amato T; Denizot H; Dubertret C; Dubreucq J; Faget C; Gabayet F; Llorca PM; Mallet J; Misdrahi D; Passerieux C; Richieri R; Rey R; Schandrin A; Urbach M; Vidailhet P; Boyer L; Schürhoff F;
Eur Arch Psychiatry Clin Neurosci; 2017 Aug; 267(5):465-472. PubMed ID: 28238173
[TBL] [Abstract][Full Text] [Related]
5. Current (but not ex) cigarette smoking is associated with worse cognitive performances in schizophrenia: results from the FACE-SZ cohort.
Mallet J; Godin O; Dansou Y; Mazer N; Scognamiglio C; Berna F; Boyer L; Capdevielle D; Chéreau I; D'Amato T; Dubreucq J; Fond G; Leigner S; Llorca PM; Misdrahi D; Passerieux C; Rey R; Pignon B; Urbach M; Schorr B; Schürhoff F; Yann LS; Dubertret C;
Psychol Med; 2023 Aug; 53(11):5279-5290. PubMed ID: 36073848
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of and Risk Factors for Extrapyramidal Side Effects of Antipsychotics: Results From the National FACE-SZ Cohort.
Misdrahi D; Tessier A; Daubigney A; Meissner WG; Schurhoff F; Boyer L; Godin O; Bulzacka E; Aouizerate B; Andrianarisoa M; Berna F; Capdevielle D; Chereau-Boudet I; D'Amato T; Dubertret C; Dubreucq J; Faget-Agius C; Lançon C; Mallet J; Passerieux C; Rey R; Schandrin A; Urbach M; Vidailhet P; Llorca PM; Fond G;
J Clin Psychiatry; 2019 Jan; 80(1):. PubMed ID: 30695288
[TBL] [Abstract][Full Text] [Related]
7. [The 10-year findings from the FondaMental Academic Center of Expertise for Schizophrenia (FACE-SZ): Review and recommendations for clinical practice].
Schürhoff F; Fond G; Berna F; Bulzacka E; Godin O; Boyer L; Misdrahi D; Andrianarisoa M; Brunel L; Coulon N; Aouizerate B; Capdevielle D; Chereau I; D'Amato T; Dubertret C; Dubreucq J; Faget C; Gabayet F; Mallet J; Rey R; Lancon C; Passerieux C; Schandrin A; Urbach M; Vidailhet P; Leboyer M; Llorca PM;
Encephale; 2019 Feb; 45(1):9-14. PubMed ID: 30327207
[TBL] [Abstract][Full Text] [Related]
8. Relationships between low-grade peripheral inflammation and psychotropic drugs in schizophrenia: results from the national FACE-SZ cohort.
Fond G; Resseguier N; Schürhoff F; Godin O; Andrianarisoa M; Brunel L; Bulzacka E; Aouizerate B; Berna F; Capdevielle D; Chereau I; D'Amato T; Dubertret C; Dubreucq J; Faget C; Gabayet F; Lançon C; Llorca PM; Mallet J; Misdrahi D; Passerieux C; Rey R; Schandrin A; Urbach M; Vidailhet P; Boyer L; Leboyer M;
Eur Arch Psychiatry Clin Neurosci; 2018 Sep; 268(6):541-553. PubMed ID: 29127503
[TBL] [Abstract][Full Text] [Related]
9. Chronic low-grade peripheral inflammation is associated with ultra resistant schizophrenia. Results from the FACE-SZ cohort.
Fond G; Godin O; Boyer L; Berna F; Andrianarisoa M; Coulon N; Brunel L; Bulzacka E; Aouizerate B; Capdevielle D; Chereau I; D'Amato T; Dubertret C; Dubreucq J; Faget C; Leignier S; Lançon C; Mallet J; Misdrahi D; Passerieux C; Rey R; Schandrin A; Urbach M; Vidailhet P; Llorca PM; Schürhoff F; Leboyer M;
Eur Arch Psychiatry Clin Neurosci; 2019 Dec; 269(8):985-992. PubMed ID: 29808267
[TBL] [Abstract][Full Text] [Related]
10. Self-reported pain in patients with schizophrenia. Results from the national first-step FACE-SZ cohort.
Fond G; Boyer L; Andrianarisoa M; Godin O; Bulzacka E; Berna F; Brunel L; Coulon N; Aouizerate B; Capdevielle D; Chereau I; D'amato T; Denizot H; Dubertret C; Dubreucq J; Faget C; Leignier S; Mallet J; Misdrahi D; Rey R; Lancon C; Passerieux C; Schandrin A; Urbach M; Vidailhet P; Leboyer M; Schurhoff F; Llorca PM;
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jul; 85():62-68. PubMed ID: 29678770
[TBL] [Abstract][Full Text] [Related]
11. Akathisia: prevalence and risk factors in a community-dwelling sample of patients with schizophrenia. Results from the FACE-SZ dataset.
Berna F; Misdrahi D; Boyer L; Aouizerate B; Brunel L; Capdevielle D; Chereau I; Danion JM; Dorey JM; Dubertret C; Dubreucq J; Faget C; Gabayet F; Lancon C; Mallet J; Rey R; Passerieux C; Schandrin A; Schurhoff F; Tronche AM; Urbach M; Vidailhet P; Llorca PM; Fond G;
Schizophr Res; 2015 Dec; 169(1-3):255-261. PubMed ID: 26589388
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for increased duration of untreated psychosis. Results from the FACE-SZ dataset.
Fond G; Boyer L; Andrianarisoa M; Godin O; Brunel L; Bulzacka E; Coulon N; Llorca PM; Berna F; Aouizerate B; Capdevielle D; D'Amato T; Dubertret C; Dubreucq J; Faget C; Gabayet F; Mallet J; Misdrahi D; Rey R; Richieri R; Roux P; Passerieux C; Schandrin A; Tronche AM; Vidailhet P; Leboyer M; Schürhoff F;
Schizophr Res; 2018 May; 195():529-533. PubMed ID: 28888362
[TBL] [Abstract][Full Text] [Related]
13. Nicotine dependence is associated with depression and childhood trauma in smokers with schizophrenia: results from the FACE-SZ dataset.
Rey R; D'Amato T; Boyer L; Brunel L; Aouizerate B; Berna F; Capdevielle D; Chereau I; Chesnoy-Servanin G; Denizot H; Dorey JM; Dubertret C; Dubreucq J; Faget C; Gabayet F; Lancon C; Mallet J; Misdrahi D; Passerieux C; Schandrin A; Schürhoff F; Urbach M; Vidailhet P; Llorca PM; Fond G;
Eur Arch Psychiatry Clin Neurosci; 2017 Sep; 267(6):567-577. PubMed ID: 28389889
[TBL] [Abstract][Full Text] [Related]
14. Benzodiazepine long-term administration is associated with impaired attention/working memory in schizophrenia: results from the national multicentre FACE-SZ data set.
Fond G; Berna F; Boyer L; Godin O; Brunel L; Andrianarisoa M; Aouizerate B; Capdevielle D; Chereau I; Danion JM; Dubertret C; Dubreucq J; Faget C; Gabayet F; Le Gloahec T; Llorca PM; Mallet J; Misdrahi D; Rey R; Richieri R; Passerieux C; Portalier C; Roux P; Vehier A; Yazbek H; Schürhoff F; Bulzacka E;
Eur Arch Psychiatry Clin Neurosci; 2018 Feb; 268(1):17-26. PubMed ID: 28349247
[TBL] [Abstract][Full Text] [Related]
15. [Effects of tobacco on antipsychotic treatments and their symptoms in schizophrenia].
Bouhlel S; Jones Y; Msolly M; Ben Hawala S; El-Hechmi Z
Tunis Med; 2012 Apr; 90(4):311-5. PubMed ID: 22535346
[TBL] [Abstract][Full Text] [Related]
16. Sexual dysfunctions are associated with major depression, chronic inflammation and anticholinergic consumption in the real-world schizophrenia FACE-SZ national cohort.
Fond G; Godin O; Dumontaud M; Faget C; Schürhoff F; Berna F; Aouizerate B; Capdevielle D; Chereau I; D'Amato T; Dubertret C; Dubreucq J; Leignier S; Mallet J; Misdrahi D; Passerieux C; Rey R; Schandrin A; Szoke A; Urbach M; Vidailhet P; Leboyer M; Lançon C; Boyer L; Llorca PM;
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Aug; 94():109654. PubMed ID: 31125587
[TBL] [Abstract][Full Text] [Related]
17. Depressive symptoms and chronic peripheral inflammation are associated with impaired functional remission in schizophrenia independently of psychotic remission.
Fond G; Faugere M; Richieri R; Cermolacce M; Korchia T; Micoulaud-Franchi JA; Sunhary de Verville PL; Boyer L; Lançon C
J Affect Disord; 2021 Feb; 280(Pt A):267-271. PubMed ID: 33220563
[TBL] [Abstract][Full Text] [Related]
18. Hypovitaminosis D is associated with depression and anxiety in schizophrenia: Results from the national FACE-SZ cohort.
Fond G; Godin O; Schürhoff F; Berna F; Bulzacka E; Andrianarisoa M; Brunel L; Aouizerate B; Capdevielle D; Chereau I; Coulon N; D'Amato T; Dubertret C; Dubreucq J; Faget C; Lançon C; Leignier S; Mallet J; Misdrahi D; Passerieux C; Rey R; Schandrin A; Urbach M; Vidailhet P; Leboyer M; Boyer L; Llorca PM;
Psychiatry Res; 2018 Dec; 270():104-110. PubMed ID: 30245372
[TBL] [Abstract][Full Text] [Related]
19. Smoking Affects the Predictive Roles of Antioxidant Enzymes in the Clinical Response to Risperidone in Schizophrenia: A Large-scale Cohort Study.
Xiu M; Song X; Yang H; Huang X; Wu F; Zhang X
Curr Neuropharmacol; 2023; 21(10):2151-2158. PubMed ID: 37132112
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and correlates of cigarette smoking among Chinese schizophrenia inpatients receiving antipsychotic mono-therapy.
Xu YM; Chen HH; Li F; Deng F; Liu XB; Yang HC; Qi LG; Guo JH; Liu TB
PLoS One; 2014; 9(2):e88478. PubMed ID: 24520390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
